CU50 + KPV10 + BPC10

CU50, KPV10, and BPC10 form a research peptide combination with complementary antimicrobial, anti-inflammatory, and tissue-repair properties.  CU50, believed to belong to the cathelicidin peptide family, is known for broad-spectrum antimicrobial activity, immune modulation, and support for wound healing through keratinocyte stimulation and enhanced stability in human serum.

KPV10, a tripeptide fragment of α-MSH, exhibits potent anti-inflammatory effects by inhibiting NF-κB signalling. It reduces cytokine activity and promotes tissue repair through fibroblast stimulation.

BPC10, likely derived from BPC-157, has demonstrated regenerative potential in tendon, ligament, bone, gastrointestinal, and neuroprotective studies by enhancing growth factor activity and nitric oxide regulation.

Together, these peptides work synergistically to control infection, reduce inflammation, stimulate angiogenesis, and accelerate tissue healing through multiple complementary biological pathways.